Navigation Links
Comprehensive overview of Children's Interstitial Lung Disease (chILD) in special issue of Pediatric Allergy, Immunology, and Pulmonology

New Rochelle, NY, May 25, 2010An insightful and in-depth presentation of the most up-to-date clinical and research findings and historical perspectives on pediatric interstitial lung disease (ILD) is presented in a special issue published online ahead of print in Pediatric Allergy, Immunology, and Pulmonology (PED), a peer-reviewed journal published by Mary Ann Liebert, Inc. ( The entire issue is available free online. (

This special focus issue includes a series of compelling roundtable discussions, interviews, clinical studies, and research articles that describe the scope and evolution of ILD in infants and children organized by Guest Editor Robin R. Deterding, MD. In the article entitled "Genetic Basis of Children's Interstitial Lung Disease," Lawrence M. Nogee, MD, from Johns Hopkins University School of Medicine (Baltimore, MD) details the specific genetic causes of chILD discovered over the past decade that have allowed for the development of noninvasive diagnostic tests and are helping to identify new targets for therapeutic drug discovery.

Stephan W. Glasser, MD and William D. Hardie, MD, from Cincinnati Children's Hospital Medical Center in Ohio, together with James S. Hagood, MD, from the University of California, San Diego, coauthored the article "Pathogenesis of Interstitial Lung Disease in Children and Adults," in which they explore the mechanisms by which the same genetic abnormalities can give rise to different clinical presentations of ILD among infants, older children, and adults.

Julie McDougal, RRT, MAE, University of Alabama at Birmingham, Ann Gettys, MS, Children's Interstitial Lung Disease Foundation, Norman, OK, and James S. Hagood, MD, describe the collaborative effort to produce the chILD-specific family educational resource "Get Up and Go With chILD!" and emphasize the need for providing families caring for a child with chILD with accurate, understandable, and useful information in their article, "chILD Family Education."

The issue is dedicated to Dr. Bettina Hilman, a pioneer in the field of chILD and Editor-in-Chief of the Journal from 1999-2009 under its former title, Pediatric Asthma, Allergy & Immunology. Dr. Hilman encouraged and challenged her colleagues to pursue a greater understanding and recognition of diffuse lung diseases in pediatric patients and was an early leader of the multidisciplinary effort to characterize the distinctions between ILD in adults and chILD and to develop strategies for diagnosing and treating these complex disorders.

"The recent discoveries about children's interstitial lung diseases illustrate the maxim that children are not just little adults. We have found completely different disease processes in the developing lung than have been previously described in adults. It is exciting to be able to summarize all of this knowledge in one place, with excellent contributions from key individuals who lead these discoveries," says Harold Farber, MD, MSPH, Editor of Pediatric Allergy, Immunology and Pulmonology, and Associate Professor of Pediatrics, Section of Pulmonology, Baylor College of Medicine, Houston, TX.


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. Leading researchers to reveal comprehensive dos and donts for prostate cancer
2. University of Minnesota releases first ever comprehensive report of the health of college students
3. More comprehensive analysis of Klamath River basin needed to aid decision makers
4. U. of I. librarian launches comprehensive Web database of field guides
5. Scientists launch first comprehensive database of human oral microbiome
6. Collaboration between researchers yields more comprehensive portrait of brain cancer
7. First comprehensive genomic study of common cold reveals new treatment targets
8. First comprehensive inventory of life in Antarctica
9. Scientists develop method for comprehensive proteome analysis
10. Comprehensive genetic study paves way for new blood-pressure medicines
11. Uniloc Unveils Industry-First Authentication Technology for Comprehensive Protection of Critical Infrastructure
Post Your Comments:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/11/2015)... 11, 2015   MedNet Solutions , an innovative SaaS-based ... research, is pleased to announce that it will be a ... event, to be held November 17-19 in ... live demonstrations of iMedNet , MedNet,s easy-to-use, ... iMedNet has been able to deliver time and cost ...
(Date:11/9/2015)... Nov. 09, 2015 ... of the "Global Law Enforcement Biometrics ... --> ) has announced ... Enforcement Biometrics Market 2015-2019" report to ... Markets ( ) has announced the ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... CA (PRWEB) , ... November ... ... Intelligence Company, today announced tighter software integration with MarkLogic, the Enterprise NoSQL ... organizations maximize information to drive change. , Smartlogic’s Content Intelligence capabilities provide ...
(Date:11/27/2015)... CHESTERFIELD, United Kingdom , Nov. 27, 2015 /PRNewswire/--  ... specialty biopharmaceutical company, announced today that it has closed ... systems (CMDS) business to Guerbet (GBT- NYSE Euronext) in ... CMDS operations encompassed four manufacturing facilities and a total ... nearly 75 in the St. Louis ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
Breaking Biology Technology: